赛诺医疗(688108)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688108 赛诺医疗

交易中 09-27 13:14:06

{"stockData":{"symbol":"688108","market":"SH","secType":"STK","nameCN":"赛诺医疗","latestPrice":9.97,"timestamp":1727414046000,"preClose":9.57,"halted":0,"volume":3292002,"delay":0,"floatShares":413000000,"shares":413000000,"eps":-0.0058,"marketStatus":"交易中","marketStatusCode":2,"change":0.4,"latestTime":"09-27 13:14:06","open":9.6,"high":9.97,"low":9.6,"amount":32184100,"amplitude":0.0387,"askPrice":9.98,"askSize":296,"bidPrice":9.97,"bidSize":232,"shortable":0,"etf":0,"ttmEps":-0.0058,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1727420400000},"adr":0,"adjPreClose":9.57,"symbolType":"stock_kcb","openAndCloseTimeList":[[1727400600000,1727407800000],[1727413200000,1727420400000]],"highLimit":10.53,"lowLimit":8.61,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":413456000,"pbRate":4.54,"roa":"--","roe":"0.92%","epsLYR":-0.1,"committee":0.015554,"marketValue":4122000000,"floatMarketCap":4122000000,"peRate":-1718.965539,"changeRate":0.0418,"turnoverRate":0.008,"status":0},"requestUrl":"/m/hq/s/688108","defaultTab":"news","newsList":[{"id":"2470165472","title":"赛诺医疗创3个月新高 获融资净买入48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470165472","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470165472?lang=zh_cn&edition=full","pubTime":"2024-09-25 10:31","pubTimestamp":1727231468,"startTime":"0","endTime":"0","summary":"09月25日，赛诺医疗股价大幅上涨，截至10点31分，赛诺医疗上涨5.03%，报9.60元/股，创近3个月新高，成交3417万元，换手率0.88%，振幅4.38%。资金动向截止发稿，赛诺医疗获得主力净流入116万元，其中超大单流出256万元，大单流入373万元。融资融券方面，赛诺医疗09月23日获得融资净买入48万元，当日该股融资余额为1.96亿元，当较前一日增加0.25%，实现2连增；该股融券余额为49万元，融券余量为5.13万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925104133a1dc5979&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925104133a1dc5979&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688108","BK0251"],"gpt_icon":0},{"id":"2469513734","title":"9月24日赛诺医疗涨5.18%，国泰江源优势精选混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2469513734","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469513734?lang=zh_cn&edition=full","pubTime":"2024-09-24 16:36","pubTimestamp":1727167000,"startTime":"0","endTime":"0","summary":"证券之星消息，9月24日赛诺医疗涨5.18%，收盘报9.14元，换手率1.6%，成交量6.62万手，成交额5941.97万元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为国泰江源优势精选混合A。国泰江源优势精选混合A目前规模为18.12亿元，最新净值1.3241，较上一交易日下跌0.05%，近一年下跌21.21%。国泰江源优势精选混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092400024477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688108","BK0251"],"gpt_icon":0},{"id":"2469604451","title":"赛诺医疗涨5.18%，东吴证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2469604451","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469604451?lang=zh_cn&edition=full","pubTime":"2024-09-24 16:36","pubTimestamp":1727166993,"startTime":"0","endTime":"0","summary":"今日赛诺医疗涨5.18%，收盘报9.14元。2024年8月23日，东吴证券研究员朱国广发布了对赛诺医疗的研报《2024年中报点评：冠脉集采续约维持较高放量，颅内自膨支架成长空间足》，该研报对赛诺医疗给出“买入”评级。考虑公司研发平台壁垒较高、创新性单品未来潜力较大、以及集采类产品的出货量增长带动了盈利大幅改善，我们维持“买入”评级。赛诺医疗个股概况：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092400024472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","688108"],"gpt_icon":0},{"id":"2469939436","title":"赛诺医疗大幅上涨 美瞳市场存安全隐患","url":"https://stock-news.laohu8.com/highlight/detail?id=2469939436","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469939436?lang=zh_cn&edition=full","pubTime":"2024-09-24 13:26","pubTimestamp":1727155565,"startTime":"0","endTime":"0","summary":"09月24日，赛诺医疗股价大幅上涨，截至13点26分，赛诺医疗上涨5.06%，报9.13元/股，成交3296万元，换手率0.90%，振幅6.10%。但据《法治日报》报道，当前美瞳市场仍存有相当程度的风险隐患。更有媒体调查发现，按照医疗器械要求销售美瞳产品的商家“少之又少”。资金动向截止发稿，赛诺医疗获得主力净流入162万元，其中超大单流出64万元，大单流入226万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924132928a1dc1974&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924132928a1dc1974&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688108"],"gpt_icon":0},{"id":"2468220692","title":"赛诺医疗09月20日主力资金流出222万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2468220692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468220692?lang=zh_cn&edition=full","pubTime":"2024-09-20 15:19","pubTimestamp":1726816774,"startTime":"0","endTime":"0","summary":"09月20日, 赛诺医疗股价跌1.35%，报收8.80元，成交金额3165万元，换手率0.87%，振幅2.58%，量比0.83。赛诺医疗今日主力资金净流出222万元，连续5日净流出，上一交易日主力净流出485万元，今日环比减少54.23%。该股近5个交易日下跌5.07%，主力资金累计净流出2078万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出158万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409201536489f098149&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409201536489f098149&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688108"],"gpt_icon":0},{"id":"2464397833","title":"赛诺医疗创1月新高 医疗器械可用性工程实验室启用","url":"https://stock-news.laohu8.com/highlight/detail?id=2464397833","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464397833?lang=zh_cn&edition=full","pubTime":"2024-09-04 11:05","pubTimestamp":1725419142,"startTime":"0","endTime":"0","summary":"消息解读9月3日，浙江省医疗器械检验研究院临平经济技术开发区院区二期项目正式启用。其中，浙江省首个具备仿真模拟环境的医疗器械可用性工程研究实验室投入使用，填补了浙江在医疗器械可用性工程测试领域的空白，补全了医疗器械产学研检用一体发展的关键一环。主营业务及业绩赛诺医疗公司主营业务为高端介入医疗器械研发、生产、销售，产品管线涵盖心血管、脑血管、结构性心脏病等介入治疗重点领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240904110652ab61cd83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240904110652ab61cd83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688108","BK0251","159883"],"gpt_icon":0},{"id":"2463207787","title":"西南证券：给予赛诺医疗买入评级，目标价位8.87元","url":"https://stock-news.laohu8.com/highlight/detail?id=2463207787","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463207787?lang=zh_cn&edition=full","pubTime":"2024-08-30 16:41","pubTimestamp":1725007306,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司近期对赛诺医疗进行研究并发布了研究报告《2024年中报点评：24H1业绩符合预期，静待神介新品放量》，本报告对赛诺医疗给出买入评级，认为其目标价位为8.87元，当前股价为8.55元，预期上涨幅度为3.74%。考虑到目前神经介入在成长周期，行业beta仍旧存在。给予2024年8倍PS估值，对应目标价8.87元，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级6家；过去90天内机构目标均价为11.08。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083000029348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600369","688108"],"gpt_icon":0},{"id":"2463015132","title":"西南证券给予赛诺医疗买入评级 2024年中报点评：24H1业绩符合预期 静待神介新品放量 目标价格为8.87元","url":"https://stock-news.laohu8.com/highlight/detail?id=2463015132","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463015132?lang=zh_cn&edition=full","pubTime":"2024-08-30 15:55","pubTimestamp":1725004500,"startTime":"0","endTime":"0","summary":"西南证券08月30日发布研报称，给予赛诺医疗（688108.SH，最新价：8.55元）买入评级，目标价格为8.87元。评级理由主要包括：1）24H1营收增速明显，主要靠冠脉介入业务的带动；2）神经介入陆续步入收获期，多款重磅产品打开成长天花板；3）推进海外销售，加快国际化布局。风险提示：新产品研发失败或注册延迟的风险，重要原材料供应风险，海外市场运营风险及汇率风险。AI点评：赛诺医疗近一个月获得2份券商研报关注，买入2家。（文章来源：每日经济新闻）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024083015570995d290ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024083015570995d290ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688108","600369"],"gpt_icon":0},{"id":"2463524054","title":"天津板块盘中拉升，赛诺医疗涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463524054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463524054?lang=zh_cn&edition=full","pubTime":"2024-08-30 09:51","pubTimestamp":1724982707,"startTime":"0","endTime":"0","summary":"08月30日，天津板块盘中拉升，截至09点51分，天津板块整体指数上涨0.52%，报1279.320点。从个股上来看，该板块的成分股中，赛诺医疗涨5.38%，唯捷创芯涨幅超过5%。从资金上来看，截止发稿，天津板块主力净流入为2228.68万，其中中科曙光受到资金热捧，主力净流入3873.47万；拉长时间线来看，该板块近20日主力资金净流入-61.91亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240830095147af9786f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240830095147af9786f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688108"],"gpt_icon":0},{"id":"2463009174","title":"8月29日赛诺医疗涨5.13%，国泰江源优势精选混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2463009174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463009174?lang=zh_cn&edition=full","pubTime":"2024-08-29 16:22","pubTimestamp":1724919734,"startTime":"0","endTime":"0","summary":"证券之星消息，8月29日赛诺医疗涨5.13%，收盘报7.99元，换手率1.82%，成交量7.53万手，成交额5947.39万元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为国泰江源优势精选混合A。国泰江源优势精选混合A目前规模为18.12亿元，最新净值1.3423，较上一交易日上涨0.04%，近一年下跌20.28%。国泰江源优势精选混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900027862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688108"],"gpt_icon":0},{"id":"2463001314","title":"赛诺医疗涨5.13%，东吴证券六日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2463001314","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463001314?lang=zh_cn&edition=full","pubTime":"2024-08-29 16:22","pubTimestamp":1724919729,"startTime":"0","endTime":"0","summary":"今日赛诺医疗涨5.13%，收盘报7.99元。2024年8月23日，东吴证券研究员朱国广发布了对赛诺医疗的研报《2024年中报点评：冠脉集采续约维持较高放量，颅内自膨支架成长空间足》，该研报对赛诺医疗给出“买入”评级。考虑公司研发平台壁垒较高、创新性单品未来潜力较大、以及集采类产品的出货量增长带动了盈利大幅改善，我们维持“买入”评级。赛诺医疗个股概况：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900027861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","688108"],"gpt_icon":0},{"id":"2463682472","title":"赛诺医疗大幅上涨 获2家券商增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2463682472","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463682472?lang=zh_cn&edition=full","pubTime":"2024-08-29 13:12","pubTimestamp":1724908352,"startTime":"0","endTime":"0","summary":"08月29日，赛诺医疗股价大幅上涨，截至13点12分，赛诺医疗上涨5.00%，报7.98元/股，成交3372万元，换手率1.05%，振幅5.79%。此外，数据统计显示，近半年内2家券商给予增持建议，10家券商给予买入建议。资金动向截止发稿，赛诺医疗获得主力净流出112万元，其中超大单流出54万元，大单流出57万元。最新财报显示，今年中报，赛诺医疗实现营业收入2.14亿元，同比增长32.49%，净利润为766.20万元，同比增长125.88%，基本每股收益为0.02元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240829131629a1d72849&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240829131629a1d72849&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688108","BK0251"],"gpt_icon":0},{"id":"2462277151","title":"赛诺医疗（688108）8月27日主力资金净买入141.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462277151","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462277151?lang=zh_cn&edition=full","pubTime":"2024-08-28 08:31","pubTimestamp":1724805073,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月27日收盘，赛诺医疗报收于7.48元，上涨0.67%，换手率0.84%，成交量3.46万手，成交额2598.95万元。近5日资金流向一览见下表：赛诺医疗融资融券信息显示，融资方面，当日融资买入152.72万元，融资偿还300.49万元，融资净偿还147.78万元。赛诺医疗主营业务：公司专注于高端介入医疗器械研发、生产、销售,产品管线涵盖心血管、脑血管、结构性心脏病等介入治疗重点领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800010429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688108","BK0251"],"gpt_icon":0},{"id":"2462513831","title":"【私募调研记录】易鑫安资管调研赛诺医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2462513831","media":"证星私募调研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462513831?lang=zh_cn&edition=full","pubTime":"2024-08-27 14:03","pubTimestamp":1724738606,"startTime":"0","endTime":"0","summary":"机构简介：易鑫安成立于2011年4月，2014年4月获批了《私募投资基金管理人登记证书》。易鑫安拥有完整的投资研究团队，核心投资经理具有长期证券投资经验，经历多轮牛熊市洗礼，对资本市场及上市公司有着长期、深刻的理解。易鑫安专注于二级市场投资，秉承日就月将、行稳致远的投资理念，致力于打造不断迭代升级、勤勉尽责的学习型组织，以客户资产持续增值为目标，追求长期复合绝对收益，为客户创造价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408271411049f5d499f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408271411049f5d499f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688108"],"gpt_icon":0},{"id":"2461602745","title":"赛诺医疗：\n目前，赛诺医疗在售产品主要集中在冠脉介入以及神经介入两大板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2461602745","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461602745?lang=zh_cn&edition=full","pubTime":"2024-08-23 20:01","pubTimestamp":1724414496,"startTime":"0","endTime":"0","summary":"证券之星消息，赛诺医疗08月23日在投资者关系平台上答复投资者关心的问题。目前，赛诺医疗在售产品主要集中在冠脉介入以及神经介入两大板块。神经介入板块，公司主要产品神经球囊及神经介入支架均已不同程度逐步参与集采。对于未来新产品上市后的定价，赛诺始终秉持着让更多患者受益的初衷，将综合考量各方面因素以确定合理价格。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082300043409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688108","BK0251"],"gpt_icon":0},{"id":"2461539054","title":"赛诺医疗(688108)：公司业绩扭亏为盈 后续管线持续推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2461539054","media":"广发证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461539054?lang=zh_cn&edition=full","pubTime":"2024-08-23 13:47","pubTimestamp":1724392043,"startTime":"0","endTime":"0","summary":"核心观点：公司24H1 业绩符合预期。根据wind，公司24 年2 季度实现营收1.23 亿元；归母净利润0.05 亿元，同比扭亏。公司费率整体下降。持续看好公司后续管线。预计24-26 年对应的营业收入分别为4.87、7.31、11.05 亿元。集采政策风险、新产品上市不及预期、持续亏损的风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082313472995b6c287&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082313472995b6c287&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688108","BK0251"],"gpt_icon":0},{"id":"2461587727","title":"太平洋：给予赛诺医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2461587727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461587727?lang=zh_cn&edition=full","pubTime":"2024-08-23 12:20","pubTimestamp":1724386857,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司谭紫媚近期对赛诺医疗进行研究并发布了研究报告《赛诺医疗点评报告：冠脉集采迅速放量，业绩持续恢复》，本报告对赛诺医疗给出买入评级，当前股价为7.35元。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级6家；过去90天内机构目标均价为11.29。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082300018150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688108","601099"],"gpt_icon":0},{"id":"2461589613","title":"太平洋给予赛诺医疗买入评级，赛诺医疗点评报告：冠脉集采迅速放量，业绩持续恢复","url":"https://stock-news.laohu8.com/highlight/detail?id=2461589613","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461589613?lang=zh_cn&edition=full","pubTime":"2024-08-23 11:02","pubTimestamp":1724382153,"startTime":"0","endTime":"0","summary":"太平洋08月23日发布研报称，给予赛诺医疗（688108.SH，最新价：7.29元）买入评级。评级理由主要包括：1）冠脉集采放量助力业绩上升，海外销售范围稳步扩大；2）神经介入引领创新，新产品开发按计划推进；3）规模效应助力毛利增长，期间费用率下降明显。风险提示：新产品研发失败或注册延迟的风险，科技人才流失的风险，重要专利和技术被侵犯的风险，集采政策带来的风险，市场竞争风险，新品上市存在不确定性的风险。AI点评：赛诺医疗近一个月获得2份券商研报关注，买入2家。文章来源：每日经济新闻原标题：太平洋给予赛诺医疗买入评级，赛诺医疗点评报告：冠脉集采迅速放量，业绩持续恢复","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082311091495b654d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082311091495b654d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["601099","688108"],"gpt_icon":0},{"id":"2461386700","title":"赛诺医疗（688108）8月21日主力资金净卖出390.58万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461386700","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461386700?lang=zh_cn&edition=full","pubTime":"2024-08-22 08:20","pubTimestamp":1724286002,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月21日收盘，赛诺医疗报收于7.39元，下跌2.51%，换手率1.0%，成交量4.12万手，成交额3070.44万元。近5日资金流向一览见下表：赛诺医疗融资融券信息显示，融资方面，当日融资买入173.01万元，融资偿还855.34万元，融资净偿还682.33万元。赛诺医疗主营业务：公司专注于高端介入医疗器械研发、生产、销售,产品管线涵盖心血管、脑血管、结构性心脏病等介入治疗重点领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082200007438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688108"],"gpt_icon":0},{"id":"2461740874","title":"东吴证券：给予赛诺医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2461740874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461740874?lang=zh_cn&edition=full","pubTime":"2024-08-22 02:20","pubTimestamp":1724264425,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广近期对赛诺医疗进行研究并发布了研究报告《2024年中报点评：冠脉集采续约维持较高放量，颅内自膨支架成长空间足》，本报告对赛诺医疗给出买入评级，当前股价为7.39元。考虑公司研发平台壁垒较高、创新性单品未来潜力较大、以及集采类产品的出货量增长带动了盈利大幅改善，我们维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有4家机构给出评级，买入评级4家；过去90天内机构目标均价为11.29。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082200002879.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","688108"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-10-30","address":"天津市滨海新区开发区第四大街5号泰达生物医药研发大厦B区2层","stockEarnings":[{"period":"1week","weight":0.0729},{"period":"1month","weight":0.2794},{"period":"3month","weight":0.0705},{"period":"6month","weight":-0.191},{"period":"1year","weight":-0.2156},{"period":"ytd","weight":-0.2375}],"companyName":"赛诺医疗科学技术股份有限公司","boardCode":"AI0035","perCapita":"38162股","boardName":"专用设备制造业","registeredCapital":"41345万元","compareEarnings":[{"period":"1week","weight":0.0968},{"period":"1month","weight":0.0534},{"period":"3month","weight":0.0113},{"period":"6month","weight":-0.0132},{"period":"1year","weight":-0.0342},{"period":"ytd","weight":0.0087}],"survey":"　　赛诺医疗科学技术股份有限公司的主营业务是高端介入医疗器械研发、生产、销售。公司的主要产品包括冠状动脉支架系统和球囊扩张导管(冠脉及神经)两大类,其中冠脉药物支架系统是公司主要收入来源。公司先后被评为“天津市重点实验室”和“天津市企业技术中心”。","serverTime":1727414050802,"listedPrice":6.99,"stockholders":"10834人(较上一季度增加6.50%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"赛诺医疗(688108)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供赛诺医疗(688108)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"赛诺医疗,688108,赛诺医疗股票,赛诺医疗股票老虎,赛诺医疗股票老虎国际,赛诺医疗行情,赛诺医疗股票行情,赛诺医疗股价,赛诺医疗股市,赛诺医疗股票价格,赛诺医疗股票交易,赛诺医疗股票购买,赛诺医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"赛诺医疗(688108)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供赛诺医疗(688108)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}